SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062074
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:12
Documents
17
Period of Report
2023-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aura-20231109.htm   iXBRL 8-K 58477
2 EX-1.1 aura-ex1_1.htm EX-1.1 447466
3 EX-5.1 aura-ex5_1.htm EX-5.1 15850
4 EX-99.1 aura-ex99_1.htm EX-99.1 265905
5 GRAPHIC img28679202_0.jpg GRAPHIC 2706
6 GRAPHIC img146020637_0.jpg GRAPHIC 9664
  Complete submission text file 0000950170-23-062074.txt   1017457

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20231109.xsd EX-101.SCH 2478
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20231109_pre.xml EX-101.PRE 10293
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20231109_lab.xml EX-101.LAB 14018
11 EXTRACTED XBRL INSTANCE DOCUMENT aura-20231109_htm.xml XML 4925
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 231392612
SIC: 2836 Biological Products, (No Diagnostic Substances)